La regulación de precios de medicamentos en Colombia: el caso del tenecteplase
Diego Rosselli +3 more
openaire +2 more sources
Savings to the Colombian health system with the implementation of externally funded oncology clinical trials [PDF]
Aruachan Vesga S +5 more
europepmc +1 more source
Financial impact of centralized purchasing of rituximab by the Brazilian Ministry of Health for lymphoma treatment, 2015-2022: an exploratory study. [PDF]
Martins RR +3 more
europepmc +1 more source
[The implications of Argentina's withdrawal from the world health organization] [PDF]
Cuestas E.
europepmc +1 more source
Missing data on accessibility of children's medicines. [PDF]
Joosse IR +4 more
europepmc +1 more source
Nurse performance in hospital financial auditing: a single case study. [PDF]
Meneguin SH, Nogueira VDSN, Bocchi SCM.
europepmc +1 more source
[The HEARTS Initiative in Cuba: experience of five years of implementationA Iniciativa HEARTS em Cuba: experiências após 5 anos de implementação]. [PDF]
Valdés González Y +6 more
europepmc +1 more source
PIN22 QUÉ FACTORES DETERMINAN LOS PRECIOS INTERNACIONALES DE LOS MEDICAMENTOS ANTIRETROVIRALES?
Garcia-Gonzalez, A +2 more
openaire +1 more source
[Right to health in Colombia: compliance with orders of the Constitutional Court to the year 2024]. [PDF]
Restrepo-Zea JH, Palacios-Romaña LD.
europepmc +1 more source
[Synthesis of evidence and recommendations: guidelines for prophylaxis and management of patients with mild and moderate COVID-19 in Latin America and the CaribbeanSíntese de evidências e recomendações: diretrizes para a profilaxia e o manejo de pacientes com COVID-19 leve e moderada na América Latina e no Caribe]. [PDF]
Organización Panamericana de la Salud.
europepmc +1 more source

